Cost Effectiveness of ABO-incompatible Kidney Transplantations
- 27 July 2006
- journal article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 82 (2) , 166-167
- https://doi.org/10.1097/01.tp.0000226104.73438.5e
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Complications, Resource Utilization, and Cost of ABO-Incompatible Living Donor Kidney TransplantationTransplantation, 2006
- ABO‐incompatible kidney transplantation using antigen‐specific immunoadsorption and rituximab: a single center experienceXenotransplantation, 2006
- ABO‐incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti‐CD20 antibody treatmentXenotransplantation, 2006
- The Stockholm experience with ABO-incompatible kidney transplantations without splenectomy.Xenotransplantation, 2006
- Plasmapheresis, CMV Hyperimmune Globulin, and Anti-CD20 Allow ABO-Incompatible Renal Transplantation Without SplenectomyAmerican Journal of Transplantation, 2004
- Excellent Long-term Outcome of ABO-Incompatible Living Donor Kidney Transplantation in JapanAmerican Journal of Transplantation, 2004
- Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximabTransplantation, 2003
- ABO-incompatible kidney transplantation using both A2 and non-A2 living donorsTransplantation, 2003